Life-Course Implications of Pediatric Risk Factors for Cardiovascular Disease

Bonita Falkner1, Samuel Gidding2

  • 1Department of Medicine/Nephrology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Insights

Cardiovascular disease (CVD) risks often start in childhood, linked to factors like obesity and high blood pressure (BP). Early interventions targeting behavioral and hereditary risks can mitigate future CVD development.

Area of Science:

  • Pediatrics
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) origins are increasingly recognized to begin in childhood.
  • Childhood risk factors like obesity, abnormal blood pressure (BP), dyslipidemia, and diabetes are linked to intermediate CVD markers in young adulthood.

Purpose of the Study:

  • To review evidence supporting the concept of childhood origins of CVD.
  • To identify modifiable and non-modifiable risk factors for CVD in children.
  • To discuss current treatment approaches for pediatric CVD risk factors.

Main Methods:

  • Review of prospective and longitudinal studies examining childhood risk factors for CVD.
  • Analysis of trajectory pathways for blood pressure from childhood to young adulthood.
  • Inclusion of data on hereditary factors, psychosocial stress, and behavioral influences.

Main Results:

  • Childhood obesity, abnormal BP, dyslipidemia, diabetes, and tobacco use associate with intermediate CVD markers (e.g., left ventricular hypertrophy, vascular stiffness).
  • Longitudinal studies reveal distinct BP trajectories leading to hypertension.
  • Familial hypercholesterolemia presents with abnormal low-density lipoprotein cholesterol in childhood.

Conclusions:

  • Childhood is a critical period for the development of cardiovascular disease risk.
  • Both non-modifiable (heredity, race) and modifiable (diet, activity, tobacco) factors contribute to pediatric CVD risk.
  • Risk management involves lifestyle modifications and pharmacologic treatments for high-risk individuals.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
660
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
179
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
122
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102
Lifestyle Factors and Health01:20

Lifestyle Factors and Health

Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
287